The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease (Q57389513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

0 references

1 reference

coronary artery disease

1 reference

1 reference

Rasmus Sejersten Ripa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Jens Jakob Thune

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Anders Bruun Mathiasen

3

object named as

Anders Bruun Mathiasen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Naja Dam Mygind

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Marina J Harutyunyan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Jens Peter Gøtze

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Julia S Johansen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Jens Kastrup

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

CLARICOR Trial Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

23 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

published in

Inflammation Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

281-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Serum YKL-40 levels in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Serum YKL-40, a new prognostic biomarker in cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Plasma YKL-40: a BMI-independent marker of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

YKL-40 is elevated in morbidly obese patients and declines after weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-010-0266-5

Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease

21 January 2018

1 reference

12 December 2020

Inflammation as a cardiovascular risk factor

1 reference

12 December 2020

YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils

1 reference

12 December 2020

Serum levels of YKL-40 increases in patients with acute myocardial infarction

1 reference

12 December 2020

YKL-40: a new biomarker in cardiovascular disease?

1 reference

12 December 2020

YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease

1 reference

12 December 2020

Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer

1 reference

12 December 2020

Increased YKL-40 expression in patients with carotid atherosclerosis

1 reference

12 December 2020

Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population

1 reference

12 December 2020

Diurnal, Weekly, and Long-Time Variation in Serum Concentrations of YKL-40 in Healthy Subjects

1 reference

12 December 2020

10.1007/S00011-010-0266-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20972697%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference